Raffaella Viti
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Cost Per Remission of Vedolizumab Versus Risankizumab for the Treatment of Moderately to Severely Active Crohn's Disease in Italy.
Journal: Advances in therapy
Published: March 14, 2026
Correction: Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy.
Journal: PharmacoEconomics - open
Published: August 20, 2025
Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy.
Journal: PharmacoEconomics - open
Published: May 09, 2024
Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: February 05, 2019
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data.
Journal: PharmacoEconomics
Published: November 01, 2018
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.
Journal: Clinical drug investigation
Published: September 08, 2018
Diabetic foot management: multidisciplinary approach for advanced lesion rescue.
Journal: The Journal of cardiovascular surgery
Published: May 29, 2018
Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF.
Journal: Reproductive biology and endocrinology : RB&E
Published: March 14, 2018
Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis.
Journal: BMJ open
Published: February 14, 2018
Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: February 03, 2018
Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective?
Journal: Clinical drug investigation
Published: May 29, 2016
Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective.
Journal: Clinical drug investigation
Published: March 05, 2016
Last Updated: 09/26/2026